We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Celanese Advances Deleveraging Through Nutrinova Sale to Mitsui
Read MoreHide Full Article
Key Takeaways
Celanese sells an additional 19% stake in Nutrinova to Mitsui for $152 million to support debt reduction.
CE retains an 11% stake in Nutrinova while targeting $1 billion in divestiture proceeds by the end of 2027.
Celanese will temporarily operate a Frankfurt diketene facility before transferring it to Nutrinova.
Celanese Corporation (CE - Free Report) continues to advance the portfolio optimization and debt-reduction efforts with the completion of the sale of an additional 19% stake in its Nutrinova food ingredients joint venture to Mitsui & Co., Ltd. This transaction generated $152 million in cash proceeds, marking another step toward the company's target of securing $1 billion in divestiture proceeds by the end of 2027.
The divestiture is an attractive realization of value for Celanese, monetizing an ownership interest that contributed approximately $4 million in equity earnings in 2025. However, the company will retain an 11% stake in the joint venture, allowing it to maintain some participation in Nutrinova's food ingredients business.
Celanese plans to utilize these proceeds toward continued deleveraging, reinforcing its focus on strengthening the financial position and reducing debt. The transaction also reflects the company's ongoing efforts to streamline its portfolio.
Celanese has agreed to temporarily own and operate a diketene facility at its Frankfurt, Germany, chemical park to ensure raw material supply continuity for the joint venture before transferring the facility to Nutrinova. All associated ownership and operating costs, including the purchase price, will be borne by Nutrinova.
CE's shares have gained 39.2% in the past year compared with the industry’s 21.4% growth.
Image Source: Zacks Investment Research
CE’s Zacks Rank & Key Picks
CE currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Basic Materials space are Reliance, Inc. (RS - Free Report) , Element Solutions Inc. (ESI - Free Report) and Worthington Steel, Inc. (WS - Free Report) .
The Zacks Consensus Estimate for RS’ 2026 earnings is pegged at $26.54 per share, indicating an 86.1% year-over-year surge. RS’shares have gained 60.4% over the past year.
The Zacks Consensus Estimate for ESI’s 2026 earnings is pegged at $1.85 per share, indicating a year-over-year rise of 24.2%. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with the average surprise being 6%.
The Zacks Consensus Estimate for WS’ current fiscal-year earnings is pinned at $4.07 per share. WS’shares have gained 24% over the past year.
Image: Bigstock
Celanese Advances Deleveraging Through Nutrinova Sale to Mitsui
Key Takeaways
Celanese Corporation (CE - Free Report) continues to advance the portfolio optimization and debt-reduction efforts with the completion of the sale of an additional 19% stake in its Nutrinova food ingredients joint venture to Mitsui & Co., Ltd. This transaction generated $152 million in cash proceeds, marking another step toward the company's target of securing $1 billion in divestiture proceeds by the end of 2027.
The divestiture is an attractive realization of value for Celanese, monetizing an ownership interest that contributed approximately $4 million in equity earnings in 2025. However, the company will retain an 11% stake in the joint venture, allowing it to maintain some participation in Nutrinova's food ingredients business.
Celanese plans to utilize these proceeds toward continued deleveraging, reinforcing its focus on strengthening the financial position and reducing debt. The transaction also reflects the company's ongoing efforts to streamline its portfolio.
Celanese has agreed to temporarily own and operate a diketene facility at its Frankfurt, Germany, chemical park to ensure raw material supply continuity for the joint venture before transferring the facility to Nutrinova. All associated ownership and operating costs, including the purchase price, will be borne by Nutrinova.
CE's shares have gained 39.2% in the past year compared with the industry’s 21.4% growth.
Image Source: Zacks Investment Research
CE’s Zacks Rank & Key Picks
CE currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Basic Materials space are Reliance, Inc. (RS - Free Report) , Element Solutions Inc. (ESI - Free Report) and Worthington Steel, Inc. (WS - Free Report) .
RS currently sports a Zacks Rank #1 (Strong Buy), while ESI and WS carry a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for RS’ 2026 earnings is pegged at $26.54 per share, indicating an 86.1% year-over-year surge. RS’shares have gained 60.4% over the past year.
The Zacks Consensus Estimate for ESI’s 2026 earnings is pegged at $1.85 per share, indicating a year-over-year rise of 24.2%. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with the average surprise being 6%.
The Zacks Consensus Estimate for WS’ current fiscal-year earnings is pinned at $4.07 per share. WS’shares have gained 24% over the past year.